Neurology Minute

American Academy of Neurology
undefined
May 15, 2025 • 2min

AAN’s President’s Award Recipient for 2025 - Part 1

In the first installment of this two-part series, Dr. Stacey Clardy engages in a thought-provoking conversation with Dr. Janis Miyasaki, asking her to share two invaluable pieces of wisdom. Show reference:  https://www.aan.com/news/aan-honors-leader-volunteer-2025-presidents-award 
undefined
May 14, 2025 • 4min

Progressive Multiple Sclerosis

Dr. Jeff Lambe talks about progressive multiple sclerosis.  Show references: https://journals.lww.com/co-neurology/abstract/2025/06000/re_defining_progression_in_multiple_sclerosis.4.aspx  https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00281-8/abstract  https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(14)70256-X/abstract  https://www.tandfonline.com/doi/full/10.1080/14737175.2022.2143265  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0288967  https://jamanetwork.com/journals/jamaneurology/article-abstract/2809772  https://www.nejm.org/doi/full/10.1056/NEJMoa2415988   
undefined
May 13, 2025 • 3min

Neuroimmunology Update 2025: Autoimmune Encephalitis Outcomes

Dr. Justin Abbatemarco discuss autoimmune encephalitis with a focus on outcomes.  Show reference:  https://www.neurology.org/doi/10.1212/WNL.0000000000210109  https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00463-5/abstract 
undefined
May 12, 2025 • 3min

Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 2

In part two of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss handling patient requests for blood-based biomarkers for Alzheimer disease and interpreting test results.
undefined
May 9, 2025 • 1min

Spontaneous Intracranial Hypotension Updates

Dr. Jessica Ailani and Dr. Kathleen Digre discuss the evolution of spontaneous intracranial hypotension (SIH) diagnosis and treatment over the past decade.
undefined
May 8, 2025 • 4min

Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 1

In part one of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss current biomarkers for Alzheimer disease and how do you use them in clinic. 
undefined
May 7, 2025 • 3min

Neuroimmunology Update 2025: MOGAD Treatments

Dr. Justin Abbatemarco discusses updates around MOGAD treatments.  Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2822964  https://jnnp.bmj.com/content/95/11/1054 
undefined
May 6, 2025 • 3min

Neuroimmunology Update 2025: Autoimmune Encephalitis Outcomes

Dr. Justin Abbatemarco discusses autoimmune encephalitis with a focus on outcomes. Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000210109  https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00463-5/abstract 
undefined
May 5, 2025 • 3min

The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting

Dr. Halley Alexander discusses the Neurology Today article, “The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting,” by Gina Shaw, available in the latest issue of Neurology Today or at neurologytoday.com.  Show reference: The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting
undefined
May 2, 2025 • 2min

Diagnosis of Alzheimer Disease Using Plasma Biomarkers

Dr. Greg Cooper and Dr. Joseph Therriault discuss the use of plasma biomarkers in diagnosing Alzheimer disease. Show reference: https://doi.org/10.1038/s43587-024-00731-y 

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app